Work

Therapeutic effects of moxa smoke-derived carbon dots in experimental rheumatoid arthritis

Year: 2026
Type: article
Abstract: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent inflammation and progressive joint damage. We isolated and purified moxa smoke-derived carbon dots (ACDs) using a smoldering-combustion aerosol-capture route, characterized their physicochemical properties, and evaluated their anti-inflammatory and anti-arthritic effects in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages and a rat model of collagen-induced arthritis (CIA). ACDs were well-dispersed, quasi-spherical nanoparticles (1.9–4.0 nm; mean, 2.9 nm) containing locally ordered sp 2 -carbon domains and oxygen- and nitrogen-containing surface groups. At concentrations ≤150 μg/mL, ACDs did not compromise RAW264.7 cell viability and attenuated LPS-evoked nitric oxide (NO) generation and IL-6 release. In CIA rats, ACDs improved clinical and histological manifestations, including arthritis scores, ankle swelling, synovial hyperplasia, inflammatory infiltration, and cartilage injury, and decreased serum NO, PGE 2 , TNF-α, IL-1β, IL-6, and IL-18. ACD treatment was also associated with reduced p38 MAPK and NF-κB phosphorylation and decreased NLRP3, ASC, cleaved caspase-1, and GSDMD-NT expression. These findings demonstrate the anti-inflammatory and anti-arthritic activity of ACDs and support further investigation of their biological effects in RA.
Language: English
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7235882200
FWCI:
Cites: 61
Cited by:
Related to: 10